Gilead Sciences, inc (GILD) Second Quarter 2021 Gilead Sciences Earnings Conference Call
Gilead Sciences, inc (NASDAQ: GILD) Q2 2021 Earnings Conference
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q1 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its first-quarter 2021 earnings today after the closing bell. The revenue increased by 16% to $6.4 billion…
Gilead Sciences, inc (GILD) Q1 2021 Earnings Call
Gilead Sciences, inc (NASDAQ: GILD) Q1 2021 Earnings Conference
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction. Adjusted…
ADVERTISEMENT
Gilead Sciences Inc. (GILD) Q2 2020 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei — Senior Director, Investor Relations Daniel O’Day — Chairman and Chief Executive…
AlphaGraphs
Infographic: Highlights from Gilead Sciences (GILD) Q2 2020 earnings
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the revenue and earnings estimates for…
Gilead Sciences Inc. (NASDAQ: GILD) Q1 2020 Earnings Call Transcript
Gilead Sciences Inc. (GILD) Q1 2020 earnings call dated April 30, 2020 Corporate Participants: Douglas Maffei — Investor Relations Daniel O’Day — Chairman and Chief Executive Officer Andrew Dickinson — Chief…
AlphaGraphs
Infographic: Highlights of Gilead Sciences (GILD) Q1 2020 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Thursday said its first-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction. The…
ADVERTISEMENT
Gilead Sciences Inc (NASDAQ: GILD) Q4 2019 Earnings Call Transcript
Gilead Sciences Inc (NASDAQ: GILD) Q4 2019 Earnings Conference Call February 04, 2020 Corporate Participants: Douglas Maffei — Investor Relations Daniel O’Day — Chairman and Chief Executive Officer Andrew Dickinson — Chief…
Market News
Gilead Sciences (GILD) stock falls as Q4 earnings miss estimates
Biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) reported a decline in fourth-quarter earnings, despite a modest increase in revenues. Earnings fell short of expectations, while…